Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:492872.
doi: 10.1155/2014/492872. Epub 2014 May 26.

Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis

Affiliations

Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis

Xu Wang et al. J Immunol Res. 2014.

Abstract

Rheumatoid arthritis (RA) is an inflammatory autoimmune disorder; abnormal T cell immunity plays a critical role in the development of RA. Recently, A20 was identified as a key negative regulator for T cell activation and inflammatory signaling and may be involved in RA pathogenesis. In this study, we analyzed the expression level of A20, NF-κB, and A20 regulatory factor mucosa-associated lymphoid tissue lymphoma translocation gene 1 (MALT1) in patients with RA. Real-time PCR was used to determine the expression level of MALT1, MALT-V1, A20, and NF-κB genes in RA and healthy individuals (HI). Significantly lower A20 expression was found in RA patients compared with those in the healthy group, while NF-κB overexpression could be detected in patients with RA. Moreover, the MALT1 and MALT1-V1 expression level was downregulated in RA patients. A positive correlation between MALT1 and A20 and MALT1-V1 and A20 was found in patients with RA, and a tendency towards a negative correlation was found between MALT1 and NF-κB, MALT1-V1 and NF-κB, and A20 and NF-κB. In conclusion, we first characterized the alternative expression pattern of MALT1, A20, and NF-κB in RA, which may be related to abnormal T cell activation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The expression level of A20 and NF-κB in patients with RA and healthy individuals.
Figure 2
Figure 2
The expression level of MALT1-V1 and total MALT1 in patients with RA and healthy individuals.
Figure 3
Figure 3
Correlation between the gene expression levels of MALT1 and A20 (a) and MALT1-V1 and A20 (b) in patients with RA.

Similar articles

Cited by

References

    1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85(3):307–310. - PubMed
    1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361. - PubMed
    1. Vinay DS, Kwon BS. Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. Cytokine. 2012;57(3):305–312. - PubMed
    1. Cooles FA, Isaacs JD. Pathophysiology of rheumatoid arthritis. Current Opinion in Rheumatology. 2011;23(3):233–240. - PubMed
    1. Campbell IK, Gerondakis S, O’Donnell K, Wicks IP. Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis. Journal of Clinical Investigation. 2000;105(12):1799–1806. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources